Investing, Innovating, Inspiring - - BioPharm International

ADVERTISEMENT

Investing, Innovating, Inspiring


BioPharm International


Ireland today, with a population of four million people, is a small member state within the European Union (EU). However, this small size has never inhibited Ireland from seeking to be a fully participating member of the global community. As a nation, Ireland has always had visions of success, allied to a pragmatic and structured approach to achieving its ambitions. This is evident in the country's ongoing emphasis on making itself attractive to investors and to intellectual talent, as Ireland continues to establish itself as a country where investment, innovation, and inspiration are of paramount importance.

Note: Details of organizations mentioned in this article can be found at http://www.biotechnologyireland.com/.

Declan McGee is the communications manager for Enterprise Ireland's Biotechnology Directorate. He is also the Editor of Irish Biotech News and http://www.biotechnologyireland.com/.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here